Appili Therapeutics Inc. (APLIF)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -3.78 Million CAD | 84.95% |
| 2023 | -25.11 Million CAD | -75.34% |
| 2022 | -14.32 Million CAD | 0.0% |
| 2021 | -14.32 Million CAD | -230.76% |
| 2020 | -4.33 Million CAD | 0.0% |
| 2019 | -4.33 Million CAD | -8.93% |
| 2018 | -3.97 Million CAD | -126.65% |
| 2017 | -1.75 Million CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.63 Million CAD | 29.53% |
| 2024 FY | -3.78 Million CAD | 84.95% |
| 2024 Q3 | -152.33 Thousand CAD | 90.7% |
| 2024 Q4 | -1.1 Million CAD | -624.36% |
| 2024 Q1 | -2.32 Million CAD | 30.26% |
| 2023 Q1 | -2.32 Million CAD | 30.26% |
| 2023 Q4 | -3.33 Million CAD | -27.26% |
| 2023 FY | -25.11 Million CAD | -75.34% |
| 2023 Q3 | -2.61 Million CAD | -59.89% |
| 2023 Q2 | -1.63 Million CAD | 29.53% |
| 2022 Q2 | -11.17 Million CAD | -51.67% |
| 2022 FY | -14.32 Million CAD | 0.0% |
| 2022 Q4 | -3.33 Million CAD | -2.91% |
| 2022 Q3 | -3.23 Million CAD | 71.02% |
| 2022 Q1 | -7.36 Million CAD | -47.82% |
| 2021 FY | -14.32 Million CAD | -230.76% |
| 2021 Q3 | -4.26 Million CAD | -72.34% |
| 2021 Q1 | -2.59 Million CAD | -101.86% |
| 2021 Q2 | -2.47 Million CAD | 4.72% |
| 2021 Q4 | -4.98 Million CAD | -16.85% |
| 2020 FY | -4.33 Million CAD | 0.0% |
| 2020 Q4 | -1.28 Million CAD | -9.02% |
| 2020 Q3 | -1.18 Million CAD | -2.68% |
| 2020 Q2 | -1.14 Million CAD | 36.09% |
| 2020 Q1 | -1.79 Million CAD | -37.7% |
| 2019 Q1 | -483.76 Thousand CAD | 65.78% |
| 2019 FY | -4.33 Million CAD | -8.93% |
| 2019 Q2 | -1.33 Million CAD | -175.51% |
| 2019 Q3 | -1.2 Million CAD | 9.37% |
| 2019 Q4 | -1.3 Million CAD | -8.16% |
| 2018 FY | -3.97 Million CAD | -126.65% |
| 2018 Q4 | -1.41 Million CAD | -38.72% |
| 2018 Q3 | -1.01 Million CAD | 0.0% |
| 2017 FY | -1.75 Million CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 94.956% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 42.505% |
| SQZ Biotechnologies Company | -79.46 Million USD | 95.242% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 107.137% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 105.805% |
| Mesoblast Limited | -87.95 Million USD | 95.701% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -107.682% |
| Genus plc | 7.9 Million USD | 147.86% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 65.286% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -1.905% |
| Marizyme, Inc. | -65.34 Million USD | 94.214% |
| ContraFect Corporation | -65.15 Million USD | 94.197% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 57.249% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | 22.618% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -118.872% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -30.719% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 53.089% |
| MultiCell Technologies, Inc. | -380.07 USD | -994693.064% |
| Accustem Sciences Inc. | -3.74 Million USD | -0.921% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 92.686% |
| EV Biologics, Inc. | -1.26 Million USD | -198.383% |
| Q BioMed Inc. | -2.05 Million USD | -84.247% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -1.283% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -497.86% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -58.804% |
| Biomind Labs Inc. | -1.21 Million USD | -211.361% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -10.54 Million USD | 64.155% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 52.159% |
| Skye Bioscience, Inc. | -37.64 Million USD | 89.956% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -74.25% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -25146.461% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 45.854% |
| IMV Inc. | -36.48 Million USD | 89.637% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 76.178% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 35.005% |
| GB Sciences, Inc. | -1.36 Million USD | -177.666% |
| Alpha Cognition Inc. | -13.77 Million USD | 72.548% |
| HST Global, Inc. | -146.21 Thousand USD | -2485.945% |
| CSL Limited | 2.64 Billion USD | 100.143% |
| Halberd Corporation | -79.67 Thousand USD | -4645.356% |
| Enzolytics Inc. | -2.17 Million USD | -73.689% |
| Resverlogix Corp. | -3.61 Million USD | -4.734% |
| Affymax, Inc. | -14.42 Million USD | 73.787% |
| SYBLEU INC | -180.3 Thousand USD | -1996.964% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -19.218% |
| argenx SE | -295.05 Million USD | 98.719% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 93.96% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 3958.071% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | 4.835% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -24.942% |
| AVAX Technologies, Inc. | -6.41 Million USD | 41.049% |
| Zenith Capital Corp. | -10.59 Million USD | 64.318% |
| Genscript Biotech Corporation | -95.47 Million USD | 96.04% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -16167.576% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | 8.804% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -6155.579% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 93.67% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -21.895% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.05 Million USD | -258.021% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -93.968% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | 0.997% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -88.563% |
| BioStem Technologies, Inc. | -8.48 Million USD | 55.429% |
| ONE Bio Corp. | 8.67 Million USD | 143.576% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -756.632% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -183.123% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -115.465% |
| Agentix Corp. | -1.37 Million USD | -175.133% |
| LadRx Corporation | 400.44 Thousand USD | 1044.182% |
| Cell Source, Inc. | -5.32 Million USD | 28.946% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -810.012% |
| Regen BioPharma, Inc. | 1.02 Million USD | 469.407% |
| Regen BioPharma, Inc. | 1.02 Million USD | 469.407% |
| NovAccess Global Inc. | -4.76 Million USD | 20.722% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 154.601% |
| Itoco Inc. | -1.86 Million USD | -102.296% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | 14.893% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -126.537% |
| Kadimastem Ltd | -3.3 Million USD | -14.317% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -1282.912% |
| CytoDyn Inc. | -49.84 Million USD | 92.414% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -4683.964% |
| Mobile Lads Corp. | -2.26 Million USD | -67.054% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -1557.371% |
| Qrons Inc. | -789.34 Thousand USD | -378.992% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -301.571% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -81.106% |
| Rebus Holdings, Inc. | -1.02 Million USD | -270.677% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -134.441% |
| International Stem Cell Corporation | -131 Thousand USD | -2786.191% |
| Bioxytran, Inc. | -4.28 Million USD | 11.661% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -6866.594% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -49.428% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 92.135% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -78.851% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -384.181% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -19.347% |
| Neutra Corp. | -233.46 Thousand USD | -1519.476% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 81.367% |
| PureTech Health plc | -65.69 Million USD | 94.245% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 82.221% |
| IXICO plc | -1.17 Million USD | -220.96% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 61.913% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 93.382% |
| CSL Limited | 2.64 Billion USD | 100.143% |
| Cellectis S.A. | -103.17 Million USD | 96.335% |